Stay updated with breaking news from Autoinflammatory Diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A randomized trial examining acupuncture in people with CSU suggests use of acupuncture could improve UAS7 scores in these patients, but investigators noted this failed to reach the threshold for significance.
Phase 3b results show risankizumab is superior for endoscopic remission and clinical remission at week 48 compared with ustekinumab, a "once in a career" result, study authors say.
The novel IL-1 inhibitor goflikicept is effective and relatively safe in idiopathic recurrent pericarditis.
A new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated.
The X-linked syndrome is a systemic autoinflammatory disease of undefined origin. It resists the classic therapeutic arsenal, but Janus kinase pathway inhibitors show promise as treatments.